Evidence map›Paper›PMID 12640135›Full record

ArticleMolecular and cellular biology2003

Common interaction surfaces of the toll-like receptor 4 cytoplasmic domain stimulate multiple nuclear targets.

Tapani Ronni, Vishal Agarwal, Michael Haykinson, Margaret E Haberland, Genhong Cheng, Stephen T Smale

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. TLR4 signaling and macrophage inflammatory responses are dampened by GIV/Girdin.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Molecular mechanisms for the subversion of MyD88 signaling by TcpC from virulent uropathogenic Escherichia coli.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Tapani RonniHoward Hughes Medical Institute and Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, California 90095, USA.
Vishal Agarwal
Michael Haykinson
Margaret E Haberland
Genhong Cheng
Stephen T Smale
Howard Hughes Medical Institute · USLaboratory of Molecular Genetics · PLUniversity of California, Los Angeles · US

Funding

CD40 SIGNALING THROUGH TNF RECEPTOR ASSOCIATED FACTORSR01GM057559 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHENG, GENHONG · 1999 to 2003
$1.3M
NIGMS NIH HHS GM57559NIGMS NIH HHS R01 GM057559
6 · The paper itself

Abstract

Toll-like receptor 4 (TLR4) mediates the host response to lipopolysaccharide (LPS) by promoting the activation of pro- and anti-inflammatory cytokine genes. To activate each gene, numerous signal transduction pathways are required. The adaptor proteins MyD88 and TIRAP contribute to the activation of several and possibly all pathways via direct interactions with TLR4's Toll/interleukin-1 receptor (IL-1R) (TIR) domain. However, additional adaptors that are required for the activation of specific subsets of pathways may exist, which could contribute to the differential regulation of target genes. Furthermore, it remains unknown whether direct interactions that have been reported between TIR domains and other proteins are required for TLR4 signaling. To address these issues, we systematically mutated the TLR4 TIR domain in the context of a CD4/TLR4 fusion protein. Several exposed residues defining at least two structural surfaces were required in macrophages for activation of the proinflammatory IL-12 p40 and anti-inflammatory IL-10 promoters, as well as promoters dependent on individual transcription factors. Interestingly, the same residues were required by all promoters tested, suggesting that the signaling pathways diverge downstream of the adaptors. The mutant phenotypes provide a framework for future studies of TLR4 signaling, as the interaction supported by each critical surface residue will need to be defined.

Indexed as

Drosophila ProteinsAnimalsCCAAT-Enhancer-Binding ProteinsCell LineCell NucleusFlow CytometryHumansInterleukin-10Interleukin-12Interleukin-12 Subunit p40KidneyMacrophagesMembrane GlycoproteinsMiceModels, MolecularMolecular Sequence DataCCAAT-Enhancer-Binding ProteinsDrosophila ProteinsInterleukin-10Interleukin-12Interleukin-12 Subunit p40Membrane GlycoproteinsNF-kappa BProtein SubunitsReceptors, Cell SurfaceRecombinant Fusion ProteinsTLR4 protein, humanToll-Like Receptor 4Toll-Like ReceptorsTranscription Factor AP-1

Identifiers

PMID12640135
PMCPMC150739
OpenAlexW2168058007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.